Aktienanalyse zu Encompass Health Corp (EHC)EHCEncompass Health Corp

Encompass Health Corporation is a provider of inpatient rehabilitation services. The Company provides specialized rehabilitative treatment, using technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability. It operates hospitals in approximately 39 states and Puerto Rico, with concentrations in Florida and Texas. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver patient care services. It offers neurological, spinal & brain-related rehabilitation, which include brain injury rehabilitation, multiple trauma rehabilitation, neurological rehabilitation, spasticity management, spinal cord injury rehabilitation and stroke rehabilitation. It also offers orthopedic & joint-related rehabilitation, which includes amputee rehabilitation, chronic condition management, hip rehabilitation and orthopedic rehabilitation. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Encompass Health Corp is a good buy right now, trading at $127.87 with a forward P/E of 18.90, which is attractive compared to the industry average. The company has shown strong financial performance with a gross margin of 90.20% and a net income of $208 million in Q2 2026, indicating robust profitability. Analysts have set a price target of $150, suggesting a potential upside of approximately 17.3%. The main risk is the current RSI of 78.09, indicating that the stock may be overbought in the short term, but the overall fundamentals and market sentiment support a long-term investment.